{"product_id":"pharma-and-profits-balancing-innovation-medicine-and-drug-prices-paperback","title":"Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices - Paperback","description":"\u003cdiv\u003e\u003cp style=\"text-align: right;\"\u003e\u003ca href=\"https:\/\/reportcopyrightinfringement.com\/\" target=\"_blank\" rel=\"nofollow\"\u003e\u003cb\u003eReport copyright infringement\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/div\u003e\u003cp\u003eby \u003cb\u003eJohn L. Lamattina\u003c\/b\u003e (Author)\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003e\u003cb\u003eHigh-level commentary on various facets of the pharmaceutical industry from a key leader in the field\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eThis book clearly explains the value that the pharmaceutical industry offers to society which is often underreported against the more negative topic of high drug prices. It also offers an overview for drug discovery and development professionals, highlighting the challenges that such drug hunters should be aware of when developing new drugs. Case studies to illustrate topics like hepatitis C, mRNA vaccines, insulin, and price controls are included to aid in seamless reader comprehension. \u003c\/p\u003e\u003cp\u003eWritten by John LaMattina, former president of Pfizer Global Research and Development and well-known speaker and writer for the pharma industry, sample topics covered and questions explored within the work include: \u003c\/p\u003e\u003cul\u003e \u003cli\u003eFiscal consequences of curing hepatitis C\u003c\/li\u003e \u003cli\u003emRNA vaccines and the race for a cure\u003c\/li\u003e \u003cli\u003eWhy the government does not deserve a piece of Biopharma's profits\u003c\/li\u003e \u003cli\u003ePaying for drugs whose ultimate value is unknown\u003c\/li\u003e \u003cli\u003eThe impact of reduced revenues on R\u0026amp;D\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eThis book is a must-read for biopharmaceutical professionals and executives who wish to gain high-level insight into key challenges that must be first understood, then overcome, within the pharmaceutical industry.\u003c\/p\u003e\u003ch3\u003eAuthor Biography\u003c\/h3\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003e\u003cb\u003eJohn LaMattina, PhD\u003c\/b\u003e is the former Senior Vice President, Pfizer Inc and President, Pfizer Global Research and Development. In this role, Dr. LaMattina oversaw the drug discovery and development efforts of over 12,000 colleagues in the United States, Europe and Asia. Currently a Senior Partner with PureTech Health, he is the author of \u003ci\u003eDrug Truths: Dispelling the Myths About Pharma R\u0026amp;D \u003c\/i\u003e(2008)\u003ci\u003e \u003c\/i\u003eand \u003ci\u003eDevalued and Distrusted - Can the pharmaceutical industry restore its broken image? \u003c\/i\u003e(2013), both published by Wiley.\u003c\/p\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eNumber of Pages:\u003c\/strong\u003e 112\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eDimensions:\u003c\/strong\u003e 0.4 x 8.7 x 5.8 IN\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e July 06, 2022\u003c\/div\u003e\n            ","brand":"BooksCloud","offers":[{"title":"Default Title","offer_id":52240789700882,"sku":"9781119881339","price":29.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0941\/2211\/5346\/files\/Zy91S0E1NG45eitWZURTZXRpNjFRUT09.webp?v=1777893654","url":"https:\/\/ckbookstore.net\/products\/pharma-and-profits-balancing-innovation-medicine-and-drug-prices-paperback","provider":"CK BOOKSTORE","version":"1.0","type":"link"}